Smith & Nephew (SNN) Acquisitions (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Acquisitions of -$186.0 million for Q4 2024, down 1140.0% year-on-year from $17.9 million in Q1 2024, and down 1140.0% on a QoQ basis from -$15.0 million in Q4 2023.
Smith & Nephew (SNN) Acquisitions (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Acquisitions for 15 consecutive years, with -$186.0 million the latest figure, recorded in Q4 2024.
- Quarterly Acquisitions fell 1140.0% year-over-year to -$186.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$557.0 million (down 9.22% YoY) and the FY2025 annual result came in at -$9.0 million, up 95.16% from the prior year.
- Acquisitions retreated to -$186.0 million in Q4 2024 per SNN's latest filing, from -$15.0 million in the prior quarter.
- Over the last five years, Acquisitions for SNN reached as high as -$15.0 million in Q4 2023 and fell as low as -$259.0 million in Q4 2021.
- A 5-year average of -$139.2 million and a median of -$139.0 million in 2020 frame the typical range for Acquisitions.
- Annual changes were most pronounced in 2023 — Acquisitions soared 84.54% — and 2024, when it sank 1140.0%.
- Year by year, Acquisitions stood at -$139.0 million in 2020, then tumbled by 86.33% to -$259.0 million in 2021, then surged by 62.55% to -$97.0 million in 2022, then surged by 84.54% to -$15.0 million in 2023, then plunged by 1140.0% to -$186.0 million in 2024.
- According to Business Quant data, Acquisitions over the past three periods registered -$186.0 million, -$15.0 million, and -$97.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -268.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -186.00 Mn |
| Dec 31, 2023 | -15.00 Mn |
| Dec 31, 2022 | -97.00 Mn |
| Dec 31, 2021 | -259.00 Mn |
| Dec 31, 2020 | -139.00 Mn |
| Dec 31, 2019 | -869.00 Mn |
| Dec 31, 2018 | -29.00 Mn |
| Jun 30, 2018 | -105.00 Mn |
| Dec 31, 2017 | -159.00 Mn |
| Dec 31, 2016 | -214.00 Mn |
| Dec 31, 2015 | -44.00 Mn |
| Dec 31, 2014 | -1.57 Bn |
| Mar 31, 2014 | -1.57 Bn |
| Dec 31, 2013 | 137.00 Mn |
| Sep 28, 2013 | 136.00 Mn |
| Jun 29, 2013 | 101.00 Mn |
| Mar 31, 2013 | -74.00 Mn |
| Dec 31, 2012 | -782.00 Mn |
| Sep 29, 2012 | 445.00 Mn |
| Jun 30, 2012 | 221.00 Mn |